Skip to main content
SpringerLink
Log in

PROMs for Juvenile Idiopathic Arthritis

  • Chapter
  • First Online:
Patient Reported Outcome Measures in Rheumatic Diseases

  • 849 Accesses

Abstract

Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children and is an important cause of short-term and long-term disability. The International League of Associations for Rheumatology has defined JIA as arthritis with no apparent cause lasting more than 6 weeks with disease onset prior to age 16. In recent years, there has been a growing interest in the assessment of parent- and child-reported outcomes (PCROs) in pediatric rheumatic diseases. A number of tools for the assessment of PCROs in children with JIA are available, including visual analog scales (VAS) for rating of a child’s overall well-being and intensity of pain, and questionnaires for the evaluation of functional ability and health-related quality of life (HRQOL). This chapter describes the most recent and widely used PCROs for the management of children with JIA.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369:767–78.

    Article  CAS  PubMed  Google Scholar 

  2. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–2.

    PubMed  Google Scholar 

  3. Foster HE, Marshall N, Myers A, Dunkley P, Griffiths ID. Outcome in adults with juvenile idiopathic arthritis—a quality of life study. Arthritis Rheum. 2003;48:767–75.

    Article  PubMed  Google Scholar 

  4. Ruperto N, Ravelli A, Levinson JE, Shear ES, Murray K, Tague BL, et al. Longterm health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. II. Early predictors of outcome. J Rheumatol. 1997;24:952–8.

    CAS  PubMed  Google Scholar 

  5. Strand CV, Russell AS. WHO/ILAR taskforce on quality of life. J Rheumatol. 1997;24:1630–3.

    CAS  PubMed  Google Scholar 

  6. Garcia-Munitis P, Bandeira M, Pistorio A, Magni-Manzoni S, Ruperto N, Schivo A, et al. Level of agreement between children, parents, and physicians in rating pain intensity in juvenile idiopathic arthritis. Arthritis Rheum. 2006;55:177–83.

    Article  PubMed  Google Scholar 

  7. Consolaro A, Vitale R, Pistorio A, Lattanzi B, Ruperto N, Malattia C, et al. Physicians' and parents' ratings of inactive disease are frequently discordant in juvenile idiopathic arthritis. J Rheumatol. 2007;34:1773–6.

    PubMed  Google Scholar 

  8. Barton JL, Imboden J, Graf J, Glidden D, Yelin EH, Schillinger D. Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2010;62:857–64.

    Article  Google Scholar 

  9. Luca N, Feldman BM. Pediatric rheumatology: improving the assessment of children with JIA. Nat Rev Rheumatol. 2011;7:442–4.

    Article  PubMed  Google Scholar 

  10. Berard R, Laxer RM. Improving the quality of care in children with juvenile idiopathic arthritis: a step in the right direction. J Rheumatol. 2011;38:789–90.

    Article  PubMed  Google Scholar 

  11. Brunner HI, Ravelli A. Developing outcome measures for paediatric rheumatic diseases. Best Pract Res Clin Rheumatol. 2009;23:609–24.

    Article  PubMed  Google Scholar 

  12. Brunner HI, Giannini EH. Health-related quality of life in children with rheumatic diseases. Curr Opin Rheumatol. 2003;15:602–12.

    Article  PubMed  Google Scholar 

  13. Filocamo G, Consolaro A, Solari N, Palmisani E, Dalprà S, et al. Recent advances in quantitative assessment of juvenile idiopathic arthritis. Ann Paediatr Rheum. 2012;1:84–96.

    Article  Google Scholar 

  14. Duffy CM. Measurement of health status, functional status, and quality of life in children with juvenile idiopathic arthritis: clinical science for the pediatrician. Pediatr Clin North Am. 2005;52:359–72. v.

    Article  PubMed  Google Scholar 

  15. Chira P, Sandborg C. Adolescent rheumatology transitional care: steps to bringing health policy into practice. Rheumatology (Oxford). 2004;43:687–9.

    Article  CAS  Google Scholar 

  16. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 1997;40:1202–9.

    Article  CAS  PubMed  Google Scholar 

  17. Wallace CA, Giannini EH, Huang B, Itert L, Ruperto N. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2011;63:929–36.

    Article  Google Scholar 

  18. Magni-Manzoni S, Ruperto N, Pistorio A, Sala E, Solari N, Palmisani E, et al. Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis. Arthritis Rheum. 2008;59:1120–7.

    Article  PubMed  Google Scholar 

  19. Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum. 2009;61:658–66.

    Article  PubMed  Google Scholar 

  20. Ruperto N, Ravelli A, Murray KJ, Lovell DJ, Andersson-Gare B, Feldman BM, et al. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford). 2003;42:1452–9.

    Article  Google Scholar 

  21. Ruperto N, Ravelli A, Cuttica R, Espada G, Ozen S, Porras O, et al. The pediatric rheumatology international trials organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the disease activity core set. Arthritis Rheum. 2005;52:2854–64.

    Article  PubMed  Google Scholar 

  22. Ruperto N, Ravelli A, Oliveira S, Alessio M, Mihaylova D, Pasic S, et al. The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus. Prospective validation of the definition of improvement. Arthritis Rheum. 2006;55:355–63.

    Article  PubMed  Google Scholar 

  23. Ruperto N, Ravelli A, Pistorio A, Ferriani V, Calvo I, Ganser G, et al. The provisional Pediatric Rheumatology International Trial Organization/American College of Rheumatology/European League Against Rheumatism disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. Arthritis Rheum. 2008;59:4–13.

    Article  PubMed  Google Scholar 

  24. Apaz MT, Saad-Magalhaes C, Pistorio A, Ravelli A, de Oliveira SJ, Marcantoni MB, et al. Health-related quality of life of patients with juvenile dermatomyositis: results from the pediatric rheumatology international trials organisation multinational quality of life cohort study. Arthritis Rheum. 2009;61:509–17.

    Article  PubMed  Google Scholar 

  25. Hasija R, Pistorio A, Ravelli A, Demirkaya E, Khubchandani R, Guseinova D, et al. Approaches for the treatment of new onset and flared juvenile dermatomyositis: an international multicenter PRINTO study. Arthritis Rheum. 2011;63:3142–52.

    Article  PubMed  Google Scholar 

  26. Lazarevic D, Pistorio A, Palmisani E, Miettunen P, Ravelli A, Pilkington C, et al. The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Ann Rheum Dis. 2013;72:686–93.

    Article  CAS  PubMed  Google Scholar 

  27. Ruperto N, Pistorio A, Ravelli A, Rider LG, Pilkington C, Oliveira S, et al. The pediatric rheumatology international trials organization provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis. Arthritis Care Res. 2010;62:1533–41.

    Article  Google Scholar 

  28. Miller FW, Rider LG, Chung YL, Cooper R, Danko K, Farewell V, et al. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford). 2001;40:1262–73.

    Article  CAS  Google Scholar 

  29. Filocamo G, Davi S, Pistorio A, Bertamino M, Ruperto N, Lattanzi B, et al. Evaluation of 21-numbered circle and 10-centimeter horizontal line visual analog scales for physician and parent subjective ratings in juvenile idiopathic arthritis. J Rheumatol. 2010;37:1534–41.

    Article  PubMed  Google Scholar 

  30. Pincus T, Bergman M, Sokka T, Roth J, Swearingen C, Yazici Y. Visual analog scales in formats other than a 10 centimeter horizontal line to assess pain and other clinical data. J Rheumatol. 2008;35:1550–8.

    Article  PubMed  Google Scholar 

  31. Sztajnbok F, Coronel-Martinez DL, Diaz-Maldonado A, Novarini C, Pistorio A, Viola S, et al. Discordance between physician's and parent’s global assessments in juvenile idiopathic arthritis. Rheumatology (Oxford). 2007;46:141–5.

    Article  CAS  Google Scholar 

  32. Miller ML, Ruprecht J, Wang D, Zhou Y, Lales G, McKenna S, et al. Physician assessment of disease activity in JIA subtypes. Analysis of data extracted from electronic medical records. Pediatr Rheumatol Online J. 2011;9:9.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Rider LG, Feldman BM, Perez MD, Rennebohm RM, Lindsley CB, Zemel LS, et al. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile dermatomyositis disease activity collaborative study group. Arthritis Rheum. 1997;40:1976–83.

    Article  CAS  PubMed  Google Scholar 

  34. Kimura Y, Walco GA. Treatment of chronic pain in pediatric rheumatic disease. Nat Clin Pract Rheumatol. 2007;3:210–8.

    Article  CAS  PubMed  Google Scholar 

  35. Anthony KK, Schanberg LE. Pain in children with arthritis: a review of the current literature. Arthritis Rheum. 2003;49:272–9.

    Article  PubMed  Google Scholar 

  36. Consolaro A, Ravelli A. Paediatric rheumatology: juvenile idiopathic arthritis—are biologic agents effective for pain? Nat Rev Rheumatol. 2013;9:447–8.

    Article  CAS  PubMed  Google Scholar 

  37. Prince FH, Geerdink LM, Borsboom GJ, Twilt M, van Rossum MA, Hoppenreijs EP, et al. Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritis. Ann Rheum Dis. 2010;69:138–42.

    Article  CAS  PubMed  Google Scholar 

  38. Ruperto N, Lovell DJ, Li T, Sztajnbok F, Goldenstein-Schainberg C, Scheinberg M, et al. Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2010;62:1542–51.

    Article  Google Scholar 

  39. Ruperto N, Ravelli A, Pistorio A, Malattia C, Cavuto S, Gado-West L, et al. Cross-cultural adaptation and psychometric evaluation of the childhood health assessment questionnaire (CHAQ) and the child health questionnaire (CHQ) in 32 countries. Review of the general methodology. Clin Exp Rheumatol. 2001;19:S1–9.

    CAS  PubMed  Google Scholar 

  40. Gutierrez-Suarez R, Pistorio A, Cespedes CA, Norambuena X, Flato B, Rumba I, et al. Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study. Rheumatology. 2007;46:314–20.

    Article  CAS  PubMed  Google Scholar 

  41. Oliveira S, Ravelli A, Pistorio A, Castell E, Malattia C, Prieur AM, et al. Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: the pediatric rheumatology international trials organization multinational quality of life cohort study. Arthritis Rheum. 2007;57:35–43.

    Article  PubMed  Google Scholar 

  42. Meiorin S, Pistorio A, Ravelli A, Iusan SM, Filocamo G, Trail L, et al. Validation of the childhood health assessment questionnaire in active juvenile systemic lupus erythematosus. Arthritis Rheum. 2008;59:1112–9.

    Article  PubMed  Google Scholar 

  43. Saad-Magalhaes C, Pistorio A, Ravelli A, Filocamo G, Viola S, Brik R, et al. Does removal of AIDS/devices and help make a difference in the childhood health assessment questionnaire disability index? Ann Rheum Dis. 2010;69:82–7.

    Article  CAS  PubMed  Google Scholar 

  44. Vilca I, Munitis PG, Pistorio A, Ravelli A, Buoncompagni A, Bica B, et al. Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial. Ann Rheum Dis. 2010;69:1479–83.

    Article  CAS  PubMed  Google Scholar 

  45. Huber AM, Hicks JE, Lachenbruch PA, Perez MD, Zemel LS, Rennebohm RM, et al. Validation of the childhood health assessment questionnaire in the juvenile idiopathic myopathies. Juvenile dermatomyositis disease activity collaborative study group. J Rheumatol. 2001;28:1106–11.

    CAS  PubMed  Google Scholar 

  46. Brunner HI, Klein-Gitelman MS, Miller MJ, Barron A, Baldwin N, Trombley M, et al. Minimal clinically important differences of the childhood health assessment questionnaire. J Rheumatol. 2005;32:150–61.

    PubMed  Google Scholar 

  47. Ruperto N, Ravelli A, Migliavacca D, Viola S, Pistorio A, Duarte C, et al. Responsiveness of clinical measures in children with oligoarticular juvenile chronic arthritis. J Rheumatol. 1999;26:1827–30.

    CAS  PubMed  Google Scholar 

  48. Dempster H, Porepa M, Young N, Feldman BM. The clinical meaning of functional outcome scores in children with juvenile arthritis. Arthritis Rheum. 2001;44:1768–74.

    Article  CAS  PubMed  Google Scholar 

  49. Lam C, Young N, Marwaha J, McLimont M, Feldman BM. Revised versions of the childhood health assessment questionnaire (CHAQ) are more sensitive and suffer less from a ceiling effect. Arthritis Rheum. 2004;51:881–9.

    Article  PubMed  Google Scholar 

  50. Filocamo G, Sztajnbok F, Cespedes-Cruz A, Magni-Manzoni S, Pistorio A, Viola S, et al. Development and validation of a new short and simple measure of physical function for juvenile idiopathic arthritis. Arthritis Rheum. 2007;57:913–20.

    Article  PubMed  Google Scholar 

  51. Meiorin S, Filocamo G, Pistorio A, Magni-Manzoni S, Sztajnbok F, Cespedes-Cruz A, et al. Impact of involvement of individual joint groups on subdimensions of functional ability scales in juvenile idiopathic arthritis. Clin Exp Rheumatol. 2009;27:527–33.

    CAS  PubMed  Google Scholar 

  52. Consolaro A, Ruperto N, Filocamo G, Lanni S, Bracciolini G, Garrone M, et al. Seeking insights into the epidemiology, treatment and outcome of childhood arthritis through a multinational collaborative effort: introduction of the EPOCA study. Pediatr Rheumatol Online J. 2012;10:39.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Lovell DJ, Howe S, Shear E, Hartner S, McGirr G, Schulte M, et al. Development of a disability measurement tool for juvenile rheumatoid arthritis. The juvenile arthritis functional assessment scale. Arthritis Rheum. 1989;32:1390–5.

    Article  CAS  PubMed  Google Scholar 

  54. Howe S, Levinson J, Shear E, Hartner S, McGirr G, Schulte M, et al. Development of a disability measurement tool for juvenile rheumatoid arthritis. The juvenile arthritis functional assessment report for children and their parents. Arthritis Rheum. 1991;34:873–80.

    Article  CAS  PubMed  Google Scholar 

  55. Wright FV, Kimber JL, Law M, Goldsmith CH, Crombie V, Dent P. The juvenile arthritis functional status index (JASI): a validation study. J Rheumatol. 1996;23:1066–79.

    CAS  PubMed  Google Scholar 

  56. Iglesias MJ, Cuttica RJ, Herrera CM, Micelotta M, Pringe A, Brusco MI. Design and validation of a new scale to assess the functional ability in children with juvenile idiopathic arthritis (JIA). Clin Exp Rheumatol. 2006;24:713–8.

    CAS  PubMed  Google Scholar 

  57. Gong GW, Barrera M, Beyene J, Bhat S, Carcao M, Lord S, et al. The gap study (GapS) interview—developing a process to determine the meaning and determinants of quality of life in children with arthritis and rheumatic disease. Clin Exp Rheumatol. 2007;25:486–93.

    CAS  PubMed  Google Scholar 

  58. Adunuri NR, Feldman BM. Critical appraisal of studies measuring quality of life in juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2015;67:880–4.

    Article  Google Scholar 

  59. DJ, Ruperto N, Mouy R, Paz E, Rubio-Pérez N, Silva CA, et al. Long-term safety, efficacy, and quality of life in patients with juvenile idiopathic arthritis treated with intravenous abatacept for up to seven years. Arthritis Rheumatol. 2015;67:275–970.

    Google Scholar 

  60. Cespedes-Cruz A, Gutierrez-Suarez R, Pistorio A, Ravelli A, Loy A, Murray KJ, et al. Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis. Ann Rheum Dis. 2008;67:309–14.

    Article  CAS  PubMed  Google Scholar 

  61. Manners PJ, Diepeveen DA. Prevalence of juvenile chronic arthritis in a population of 12-year-old children in urban Australia. Pediatrics. 1996;98:84–90.

    CAS  PubMed  Google Scholar 

  62. Tucker LB. Whose life is it anyway? Understanding quality of life in children with rheumatic diseases. J Rheumatol. 2000;27:8–11.

    CAS  PubMed  Google Scholar 

  63. Burgos-Vargas R. Assessment of quality of life in children with rheumatic disease. J Rheumatol. 1999;26:1432–5.

    CAS  PubMed  Google Scholar 

  64. Coulton CJ, Zborowsky E, Lipton J, Newman AJ. Assessment of the reliability and validity of the arthritis impact measurement scales for children with juvenile arthritis. Arthritis Rheum. 1987;30:819–24.

    Article  CAS  PubMed  Google Scholar 

  65. Duffy CM, Arsenault L, Duffy KN, Paquin JD, Strawczynski H. The juvenile arthritis quality of life questionnaire—development of a new responsive index for juvenile rheumatoid arthritis and juvenile spondyloarthritides. J Rheumatol. 1997;24:738–46.

    CAS  PubMed  Google Scholar 

  66. Landgraf JM, Abetz L, Ware JE. The CHQ user’s manual. 1st ed. Boston: The Health Institute, New England Medical Center; 1996.

    Google Scholar 

  67. Varni JW, Seid M, Knight TS, Burwinkle T, Brown J, Szer IS. The PedsQL(TM) in pediatric rheumatology—reliability, validity, and responsiveness of the pediatric quality of life inventory(TM) generic core scales and rheumatology module. Arthritis Rheum. 2002;46:714–25.

    Article  PubMed  Google Scholar 

  68. Arkela-Kautiainen M, Haapasaari J, Kautiainen H, Vilkkumaa I, Malkia E, Leirisalo-Repo M. Favourable social functioning and health related quality of life of patients with JIA in early adulthood. Ann Rheum Dis. 2005;64:875–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Filocamo G, Schiappapietra B, Bertamino M, Pistorio A, Ruperto N, Magni-Manzoni S, et al. A new short and simple health-related quality of life measurement for paediatric rheumatic diseases: initial validation in juvenile idiopathic arthritis. Rheumatology (Oxford). 2010;49:1272–80.

    Article  Google Scholar 

  70. Bulatovic M, Heijstek MW, Verkaaik M, Van Dijkhuizen EH, Armbrust W, Hoppenreijs EP, et al. High prevalence of methotrexate intolerance in juvenile idiopathic arthritis: development and validation of a methotrexate intolerance severity score. Arthritis Rheum. 2011;63:2007–13.

    Article  CAS  PubMed  Google Scholar 

  71. Filocamo G, Consolaro A, Ferrari C, Ravelli A. Introducing new tools for assessment of parent- and child-reported outcomes in paediatric rheumatology practice: a work in progress. Clin Exp Rheumatol. 2013;31:964–8.

    PubMed  Google Scholar 

  72. Filocamo G, Consolaro A, Schiappapietra B, Dalpra S, Lattanzi B, Magni-Manzoni S, et al. A new approach to clinical care of juvenile idiopathic arthritis: the juvenile arthritis multidimensional assessment report. J Rheumatol. 2011;38:938–53.

    Article  PubMed  Google Scholar 

  73. Filocamo G, Consolaro A, Schiappapietra B, Ruperto N, Pistorio A, Solari N, et al. Parent and child acceptable symptom state in juvenile idiopathic arthritis. J Rheumatol. 2012;39:856–63.

    Article  PubMed  Google Scholar 

  74. Consolaro A, Ruperto N, Pistorio A, Lattanzi B, Solari N, Galasso R, et al. Development and initial validation of composite parent- and child-centered disease assessment indices for juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2011;63:1262–70.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Università degli studi di Genova, Genoa, Italy

    Alessandro Consolaro M.D., Ph.D. & Angelo Ravelli M.D.

  2. Pediatria 2, Reumatologia, Istituto Giannina Gaslini, Genoa, Italy

    Alessandro Consolaro M.D., Ph.D., Stefano Lanni M.D., Angelo Ravelli M.D. & Nicolino Ruperto M.D., M.P.H.

Authors
  1. Alessandro Consolaro M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stefano Lanni M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Angelo Ravelli M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nicolino Ruperto M.D., M.P.H.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicolino Ruperto M.D., M.P.H. .

Editor information

Editors and Affiliations

  1. Honorary Senior Clinical Lecturer, King’s College London, London, United Kingdom

    Yasser El Miedany

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Consolaro, A., Lanni, S., Ravelli, A., Ruperto, N. (2016). PROMs for Juvenile Idiopathic Arthritis. In: El Miedany, Y. (eds) Patient Reported Outcome Measures in Rheumatic Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-32851-5_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-32851-5_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-32849-2

  • Online ISBN: 978-3-319-32851-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation